Parkworth Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$638 Sell
66
-8
-11% -$83 ﹤0.01% 558
2025
Q1
$1.1K Buy
74
+5
+7% +$77 ﹤0.01% 244
2024
Q4
$1.02K Buy
+69
New +$1.12K ﹤0.01% 277

Other funds holding OGN

Parkworth Wealth Management's OGN Position: Q2 2025 in Review

Parkworth Wealth Management reduced its Organon & Co (OGN) stake by 11% in Q2 2025, selling an estimated $83 and leaving 66 shares worth $638. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Parkworth Wealth Management first reported a position in OGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.1K in Q1 2025. 694 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Parkworth Wealth Management held 66 shares of Organon & Co worth $638 as of Q2 2025.
  • Parkworth Wealth Management sold 8 Organon & Co shares in Q2 2025, an estimated $83.
  • Organon & Co made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #558 holding.
  • Parkworth Wealth Management first reported a position in Organon & Co in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Organon & Co position peaked at $1.1K in Q1 2025.
  • 694 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.